<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04858464</url>
  </required_header>
  <id_info>
    <org_study_id>E-77082166-604.01.02-27503</org_study_id>
    <nct_id>NCT04858464</nct_id>
  </id_info>
  <brief_title>Reliability, Validity of the Turkish Version of the Primary Sjögren Syndrome Quality of Life (PSS-QoL) Questionnaire</brief_title>
  <official_title>Reliability, Validity, and Cross-Cultural Adaptation of the Turkish Version of the Primary Sjögren Syndrome Quality of Life (PSS-QoL) Questionnaire</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gazi University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gazi University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study was to investigate adaptation, validity, and reliability of the&#xD;
      Turkish version of the Primary Sjögren's Syndrome Quality of Life (PSS-QoL) Questionnaire&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary Sjögren's Syndrome (PSS) is a chronic systemic disease characterized by lymphocytic&#xD;
      infiltration of exocrine glands. Dryness, chronic pain, physical fatigue, glandular and&#xD;
      extraglandular symptoms seen in PSS cause deterioration of the health-related quality of&#xD;
      life.&#xD;
&#xD;
      The Primary Sjögren's Syndrome Quality of Life (PSS-QoL) Questionnaire has recently developed&#xD;
      as a patient-reported condition-specific outcome measurement tool to assess the quality of&#xD;
      life associated with PSS. The PSS-QoL questionnaire consists of 25 questions with a physical&#xD;
      and psychosocial dimension.The physical dimension consists of a numeric rating scale (NRS,&#xD;
      ranging from 0 to 10) for pain and physical symptoms. The question related to vaginal dryness&#xD;
      is intended to be answered by women only. Each &quot;yes&quot; answer about physical symptoms-related&#xD;
      questions adds 1 point to the score. The psychosocial dimension can be scored on a 5-point&#xD;
      Likert scale and contains 14 question with the following possible answers: never (0), rarely&#xD;
      (1), sometimes (2), often (3), and always (4). The PSS-QoL score ranges from 0-96 (for women)&#xD;
      and 0-92 (excluding the question of vaginal dryness for men). After questioning the&#xD;
      sociodemographic characteristics of the individuals, PSS-QoL, EuroQuol-5D, the EULAR&#xD;
      Sjögren's Syndrome Disease Activity Index and EULAR Sjögren's Syndrome Patient Reported Index&#xD;
      will be used. Test-retest will be re-applied to those of the same individuals who can be&#xD;
      reached after 1 week. The results will be analyzed using the SPSS version 22.0 computer&#xD;
      package program.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 2, 2021</start_date>
  <completion_date type="Anticipated">May 2, 2023</completion_date>
  <primary_completion_date type="Anticipated">May 2, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Primary Sjögren's Syndrome Quality of Life (PSS-QoL) Questionnaire</measure>
    <time_frame>10 minutes</time_frame>
    <description>Primary Sjögren's Syndrome Quality of Life (PSS-QoL) Questionnaire was designed to evaluate measurement of health related quality of life in patients with primary Sjögren's syndrome.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Primary Sjögren's Syndrome</condition>
  <arm_group>
    <arm_group_label>Patients group</arm_group_label>
    <description>Individuals with primary Sjögren's syndrome</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Survey study</intervention_name>
    <description>Patients will complete the mentioned questionnaires.</description>
    <arm_group_label>Patients group</arm_group_label>
    <other_name>Questionnaire application</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with primary Sjögren's syndrome between the ages of 18-90&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosed with primary Sjögren's syndrome&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Having neurological and cognitive disorders,&#xD;
&#xD;
          -  Having another rheumatological diseases&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Deran Oskay, Assoc. Prof</last_name>
    <role>Study Director</role>
    <affiliation>Gazi University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Selin Bayram, Msc</last_name>
    <phone>05327001805</phone>
    <email>selinbayram94@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Gazi University</name>
      <address>
        <city>Ankara</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Selin Bayram, Msc</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Lackner A, Stradner MH, Hermann J, Unger J, Stamm T, Graninger WB, Dejaco C. Assessing health-related quality of life in primary Sjögren's syndrome-The PSS-QoL. Semin Arthritis Rheum. 2018 Aug;48(1):105-110. doi: 10.1016/j.semarthrit.2017.11.007. Epub 2017 Nov 27.</citation>
    <PMID>29395257</PMID>
  </reference>
  <reference>
    <citation>Ng WF, Bowman SJ. Primary Sjogren's syndrome: too dry and too tired. Rheumatology (Oxford). 2010 May;49(5):844-53. doi: 10.1093/rheumatology/keq009. Epub 2010 Feb 10. Review.</citation>
    <PMID>20147445</PMID>
  </reference>
  <reference>
    <citation>Lackner A, Ficjan A, Stradner MH, Hermann J, Unger J, Stamm T, Stummvoll G, Dür M, Graninger WB, Dejaco C. It's more than dryness and fatigue: The patient perspective on health-related quality of life in Primary Sjögren's Syndrome - A qualitative study. PLoS One. 2017 Feb 9;12(2):e0172056. doi: 10.1371/journal.pone.0172056. eCollection 2017.</citation>
    <PMID>28182787</PMID>
  </reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>April 21, 2021</study_first_submitted>
  <study_first_submitted_qc>April 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 26, 2021</study_first_posted>
  <last_update_submitted>August 31, 2021</last_update_submitted>
  <last_update_submitted_qc>August 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Gazi University</investigator_affiliation>
    <investigator_full_name>Selin Bayram</investigator_full_name>
    <investigator_title>Msc</investigator_title>
  </responsible_party>
  <keyword>Primary Sjögren's Syndrome</keyword>
  <keyword>Quality of Life</keyword>
  <keyword>Patient-reported Outcome</keyword>
  <keyword>Reliability</keyword>
  <keyword>Validity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sjogren's Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

